About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT03557086

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

The goal of this pilot randomized trial is to assess the feasibility and preliminary efficacy of an advanced care planning (ACP) video decision support tool for improving patients' knowledge regarding...

Lead sponsor: Massachusetts General Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Massachusetts General Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. ≥ 18 years of age with an established diagnosis of end-stage liver disease
•2. Patient must have either 1) primary hepatologist at the MGH Liver Center or an MGH-affiliated primary care physician, or 2) a previous inpatient admission at MGH
•3. Deemed ineligible for liver transplantation as determined by the primary hepatologist
•4. Ability to communicate in English and provide informed consent
•5. A score ≥ 7 on the Short Portable Mental Status Questionnaire

Exclusion Criteria

•1. Severe hepatic encephalopathy which the primary hepatologist believes prohibits informed consent or participation in the study
•2. Significant uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the primary hepatologist believes prohibits informed consent or participation in the study
•3. Prior history of liver transplantation
•4. Patient has been referred to or enrolled in hospice care
•5. Patients who have been referred to palliative care

Related studies

RECRUITINGPhase 1

A Study of SIPLIZUMAB in AILD and LT Patients

NCT06455280 · Autoimmune Liver Disease, Liver Transplant Disorder, and more

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

NCT03803423 · End Stage Renal Disease, End Stage Liver Disease

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

NCT06136221 · Cirrhosis, Liver, End Stage Liver DIsease, and more

Vienna Hypothermic Oxygenated Machine Perfusion Study

NCT06418165 · End Stage Liver Disease, Hepatocellular Carcinoma

Active Not RecruitingPhase 2

Tocotrienol Against the Progression of End Stage Liver Disease

NCT02581085 · End Stage Liver Disease, NASH - Nonalcoholic Steatohepatitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 18, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateSep 2018

Last updatedMar 18, 2024

Condition

End Stage Liver Disease

Locations shown

Massachusetts General Hospital

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 18, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions